Skip to main content
SpringerLink
Log in

Endocrine Surgery in Cirrhotic Patients

  • Chapter
  • First Online:
Surgical Procedures on the Cirrhotic Patient

  • 1083 Accesses

Abstract

Cirrhosis with chronic liver failure is a disease capable of affecting a variety of organ systems. As the prevalence of chronic liver disease increases, more patients undergoing elective surgery will have concomitant liver failure (O’Leary et al. 13:211, 2009). It is well documented that cirrhotic patients undergoing procedures under general anesthesia have perioperative mortality ranging from 8.3% to 25% (Millwala et al. 13:4056–4063, 2007). As the liver plays a vital function in a number of metabolic pathways, dysfunction of the liver can target several endocrine organs. As such, surgical management of endocrine disorders requires astute knowledge of the role of advanced liver disease in endocrine disorders and prudent judgment in the selection of patients that will undergo surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bianco AC, Larsen PR. Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD, editors. The Thyroid: Fundamental and Clinical Text. Philadelphia: Lippincott Williams and Wilkins; 2005.

    Google Scholar 

  2. Burra P. Liver abnormalities and endocrine diseases. Best Pract Res Clin Gastroenterol. 2013;27:553–63.

    Article  CAS  PubMed  Google Scholar 

  3. Burra P, Franklyn JA, Ramsden DB, Elias E, Sheppard MC. Severity of alcoholic liver disease and markers of thyroid and steroid status. Postgrad Med J. 1992;68:804–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Antonelli A, Ferri C, Fallahi P, et al. Thyroid cancer in HCV-related chronic hepatitic patients: a case-control study. Thyroid. 2007;17:447–51.

    Article  CAS  PubMed  Google Scholar 

  5. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159.

    Article  PubMed  Google Scholar 

  7. Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999;29:1617.

    Article  CAS  PubMed  Google Scholar 

  8. Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90:42.

    Article  CAS  PubMed  Google Scholar 

  9. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261.

    Article  PubMed  Google Scholar 

  10. Friedman LS, Maddrey WC. Surgery in the patient with liver disease. Med Clin North Am. 1987;71:453.

    Article  CAS  PubMed  Google Scholar 

  11. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864.

    Article  CAS  PubMed  Google Scholar 

  12. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for end-stage liver disease (MELD) predicts non-transplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242:244–51.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pons Y, Gauthier J, Ukkola-Pons E, et al. Comparison of LigaSure vessel sealing system, harmonic scalpel, and conventional hemostasis in total thyroidectomy. Otolaryngol Head Neck Surg. 2009;141:496.

    Article  PubMed  Google Scholar 

  14. Siperstein AE, Berber E, Morkoyun E. The use of the harmonic scalpel vs. conventional knot tying for vessel ligation in thyroid surgery. Surgery. 2002;137:137–42.

    Google Scholar 

  15. Ecker T, Carvalho AL, Choe JH, et al. Hemostasis in thyroid surgery: harmonic scalpel versus other techniques–a meta-analysis. Otolaryngol Head Neck Surg. 2010;143:17.

    Article  PubMed  Google Scholar 

  16. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:2036.

    CAS  PubMed  Google Scholar 

  17. Oldenburg WA, Van Heerden PA, Sizemore GW, Abbound CF, Sheedy PF. Hypercalcemia and primary hepatic tumors. Arch Surg. 1982;117:1363–6.

    Article  CAS  PubMed  Google Scholar 

  18. Luo JC, Hwang SJ, Wu JC, et al. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer. 1999;86:799–804.

    Article  CAS  PubMed  Google Scholar 

  19. Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, Chang FY, Chiang JH, Lui WY, Chu CW, Lee SD. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology. 2002;49:1315–9.

    PubMed  Google Scholar 

  20. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31:48.

    Article  CAS  PubMed  Google Scholar 

  21. Grey A, Lucas J, Horne A, et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab. 2005;90:2122.

    Article  CAS  PubMed  Google Scholar 

  22. Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kumar R. Hepatic and intestinal osteodystrophy and the hepatobiliary metabolism of vitamin D. Ann Intern Med. 1983;98:662.

    Article  CAS  PubMed  Google Scholar 

  24. Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26:591–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int. 2011;24:43–50.

    Article  CAS  PubMed  Google Scholar 

  26. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51:1158–67.

    Article  CAS  PubMed  Google Scholar 

  27. Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2010;30:417–44.

    Article  CAS  PubMed  Google Scholar 

  28. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561.

    Article  CAS  PubMed  Google Scholar 

  29. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99 m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf). 2002;57:241.

    Article  Google Scholar 

  30. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics. 2008;28:1461.

    Article  PubMed  Google Scholar 

  31. Kwon JH, Kim EK, Lee HS, et al. Neck ultrasonography as preoperative localization of primary hyperparathyroidism with an additional role of detecting thyroid malignancy. Eur J Radiol. 2013;82:e17.

    Article  PubMed  Google Scholar 

  32. Nichols KJ, Tomas MB, Tronco GG, et al. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology. 2008;248:221.

    Article  PubMed  Google Scholar 

  33. Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012;214(3):260–9.

    Article  PubMed  Google Scholar 

  34. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136(4):872–80.

    Article  PubMed  Google Scholar 

  35. Day KM, Elsayed M, Monchik JM. No need to abandon focused unilateral exploration for primary hyperparathyroidism with intraoperative monitoring of intact parathyroid hormone. J Am Coll Surg. 2015;221(2):518–23.

    Article  PubMed  Google Scholar 

  36. Norlén O, Wang KC, Tay YK, et al. No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism. Ann Surg. 2015;261(5):991–6.

    Article  PubMed  Google Scholar 

  37. Slepavicius A, Beisa V, Janusonis V, Strupas K. Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial. Langenbecks Arch Surg. 2008;393:659.

    Article  PubMed  Google Scholar 

  38. Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246:976.

    Article  PubMed  Google Scholar 

  39. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg (Published online August). 2016;10 doi:10.1001/jamasurg.2016.2310.

  40. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006;29:298.

    Article  CAS  PubMed  Google Scholar 

  41. Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011;164:851.

    Article  CAS  PubMed  Google Scholar 

  42. Katyal S, Oliver 3rd JH, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000;216:698–703.

    Article  CAS  PubMed  Google Scholar 

  43. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2009;23:273.

    Article  CAS  PubMed  Google Scholar 

  44. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JWM, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656–66.

    Article  CAS  PubMed  Google Scholar 

  45. Vilar L, Freitas Mda C, Faria M, et al. Pitfalls in the diagnosis of Cushing’s syndrome. Arq Bras Endocrinol Metabol. 2007;51:1207–16.

    Article  PubMed  Google Scholar 

  46. Hamrahian AH, Ioachimescu AG, Remer EM, et al. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab. 2005;90:871.

    Article  CAS  PubMed  Google Scholar 

  47. Rossi H, Kim A, Prinz RA. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am Surg. 2002;68:253.

    PubMed  Google Scholar 

  48. Välimäki M, Pelkonen R, Porkka L, et al. Long-term results of adrenal surgery in patients with Cushing’s syndrome due to adrenocortical adenoma. Clin Endocrinol (Oxf). 1984;20:229.

    Article  Google Scholar 

  49. Amar L, Servais A, Gimenez-Roqueplo AP, et al. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110.

    Article  CAS  PubMed  Google Scholar 

  50. Herrera MF, Grant CS, van Heerden JA, et al. Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991;110:1014.

    CAS  PubMed  Google Scholar 

  51. Angeli A, Osella G, Alì A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47:279.

    Article  CAS  PubMed  Google Scholar 

  52. Lee JE, Evans DB, Hickey RC, et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery. 1998;124(6):1115–22.

    Article  CAS  PubMed  Google Scholar 

  53. Hornstein I, Schwarz C, Ebbing S, Hoppe-Lotichius M, Otto G, Lang H, Musholt TJ. Surgical resection of metastases to the adrenal gland: a single center experience. Langenbecks Arch Surg. 2015;400(3):333–9. doi:10.1007/s00423-015-1293-z. Epub 2015 Mar 1. PubMed PMID: 25726026.

    Article  CAS  PubMed  Google Scholar 

  54. Ha TY, Hwang S, Ahn CS, Kim KH, Lee YJ, Moon DB, Song GW, Jung DH, Park GC, Lee SG. Resection of metachronous adrenal metastasis after liver resection and transplantation for hepatocellular carcinoma. Dig Surg. 2014;31(6):428–35. doi:10.1159/000370078. Epub 2015 Jan 7.

    Article  PubMed  Google Scholar 

  55. Lee J, El-Tamer M, Schifftner T, et al. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg. 2008;206:953.

    Article  PubMed  Google Scholar 

  56. Henry J, Sebag F, Iacobone M, et al. Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg. 2002;26:1043.

    Article  PubMed  Google Scholar 

  57. Ramacciato G, Mercantini P, Torre ML, et al. Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc. 2008;22:516.

    Article  PubMed  Google Scholar 

  58. Walz MK, Alesina PF, Wenger FA, et al. Posterior retroperitoneoscopic adrenalectomy–results of 560 procedures in 520 patients. Surgery. 2006;140:943.

    Article  PubMed  Google Scholar 

  59. Taskin HE, Berber E. Robotic adrenalectomy. Cancer J. 2013;19:162.

    Article  PubMed  Google Scholar 

  60. Yamakado K, Anai H, Takaki H, et al. Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in 6 patients. AJR Am J Roentgenol. 2009;192:W300–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EssentiaHealth/Duluth Clinic, 300 East 3rd St, Duluth, MN, 55805, USA

    Nisar Zaidi MD

  2. Cleveland Clinic, 9500 Euclid Ave F-20, Cleveland, OH, 44195, USA

    Eren Berber MD

Authors
  1. Nisar Zaidi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eren Berber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nisar Zaidi MD .

Editor information

Editors and Affiliations

  1. Transplantation Center, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA

    Bijan Eghtesad

  2. Department of Surgery, University of Chicago, Chicago, Illinois, USA

    John Fung

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Zaidi, N., Berber, E. (2017). Endocrine Surgery in Cirrhotic Patients. In: Eghtesad, B., Fung, J. (eds) Surgical Procedures on the Cirrhotic Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-52396-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52396-5_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52394-1

  • Online ISBN: 978-3-319-52396-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation